|
call loadScript javascripts\jsmol\core\package.js call loadScript javascripts\jsmol\core\core.z.js -- required by ClazzNode call loadScript javascripts\jsmol\J\awtjs2d\WebOutputChannel.js
|
Salicylic acid is an organic compound with the formula HOC6H4COOH. A colorless (or white), bitter-tasting solid, it is a precursor to and a metabolite of acetylsalicylic acid (aspirin). It is a plant hormone, and has been listed by the EPA Toxic Substances Control Act (TSCA) Chemical Substance Inventory as an experimental teratogen. The name is from Latin salix for willow tree, from which it was initially identified and derived. It is an ingredient in some anti-acne products. Salts and esters of salicylic acid are known as salicylates.
|
Read full article at Wikipedia
|
InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10) |
YGSDEFSMJLZEOE-UHFFFAOYSA-N |
|
Chlamydomonas reinhardtii
(NCBI:txid3055)
|
See:
PubMed
|
Cordyceps sinensis
(NCBI:txid72228)
|
Found in
mycelium
(BTO:0001436).
Ethanolic extract of dried mycelia
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor
An EC 1.11.1.* (peroxidases) inhibitor that inhibits the action of L-ascorbate peroxidase (EC 1.11.1.11).
antifungal agent
An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
algal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
plant hormone
A plant growth regulator that modulates the formation of stems, leaves and flowers, as well as the development and ripening of fruit. The term includes endogenous and non-endogenous compounds (e.g. active compounds produced by bacteria on the leaf surface) as well as semi-synthetic and fully synthetic compounds.
|
|
antiinfective agent
A substance used in the prophylaxis or therapy of infectious diseases.
keratolytic drug
A drug that softens, separates, and causes desquamation of the cornified epithelium or horny layer of skin. Keratolytic drugs are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
|
|
View more via ChEBI Ontology
Outgoing
|
salicylic acid
(CHEBI:16914)
has role
algal metabolite
(CHEBI:84735)
salicylic acid
(CHEBI:16914)
has role
antifungal agent
(CHEBI:35718)
salicylic acid
(CHEBI:16914)
has role
antiinfective agent
(CHEBI:35441)
salicylic acid
(CHEBI:16914)
has role
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor
(CHEBI:73181)
salicylic acid
(CHEBI:16914)
has role
keratolytic drug
(CHEBI:50176)
salicylic acid
(CHEBI:16914)
has role
plant hormone
(CHEBI:37848)
salicylic acid
(CHEBI:16914)
has role
plant metabolite
(CHEBI:76924)
salicylic acid
(CHEBI:16914)
is a
monohydroxybenzoic acid
(CHEBI:25389)
salicylic acid
(CHEBI:16914)
is conjugate acid of
salicylate
(CHEBI:30762)
|
|
Incoming
|
1-salicylate glucuronide
(CHEBI:73961)
has functional parent
salicylic acid
(CHEBI:16914)
2,6-dihydroxy-4-[(2R)-2-hydroxyheptyl]benzoic acid
(CHEBI:213766)
has functional parent
salicylic acid
(CHEBI:16914)
2-(D-glucosyloxy)benzoic acid
(CHEBI:87766)
has functional parent
salicylic acid
(CHEBI:16914)
2-[[2-[(2-hydroxyphenyl)-oxomethoxy]-1-oxoethyl]amino]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylic acid methyl ester
(CHEBI:121777)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxy-3-methylbenzoic acid (3-cyano-4-imino-2-oxopentyl) ester
(CHEBI:112747)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxy-4-methylbenzoic acid [2-(2-chloroanilino)-2-oxoethyl] ester
(CHEBI:116485)
has functional parent
salicylic acid
(CHEBI:16914)
2-Hydroxy-4-trifluoromethyl benzoic acid
(CHEBI:174020)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxy-5-[(4-methoxyphenyl)sulfamoyl]benzoic acid [2-[1-(3-bicyclo[2.2.1]heptanyl)ethylamino]-2-oxoethyl] ester
(CHEBI:121984)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxy-6-(12-oxoheptadecyl)benzoic acid
(CHEBI:211672)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxy-6-(12-oxopentadecyl)benzoic acid
(CHEBI:211679)
has functional parent
salicylic acid
(CHEBI:16914)
2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid
(CHEBI:174627)
has functional parent
salicylic acid
(CHEBI:16914)
2-Hydroxy-6-(8-tridecenyl)benzoic acid
(CHEBI:192876)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trien-1-yl]benzoic acid
(CHEBI:183726)
has functional parent
salicylic acid
(CHEBI:16914)
2-Hydroxy-6-pentadeca-8,11,14-trienyl benzoic acid
(CHEBI:181219)
has functional parent
salicylic acid
(CHEBI:16914)
2-Hydroxy-6-tridecylbenzoic acid
(CHEBI:175101)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester
(CHEBI:91642)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxybenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester
(CHEBI:114677)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxybenzoic acid [2-[[(1-methyl-2-pyrrolyl)-oxomethyl]amino]-2-oxoethyl] ester
(CHEBI:108199)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxybenzoyl-AMP
(CHEBI:86457)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxybenzoyl-CoA
(CHEBI:32587)
has functional parent
salicylic acid
(CHEBI:16914)
2-hydroxyethyl salicylate
(CHEBI:86541)
has functional parent
salicylic acid
(CHEBI:16914)
3,5-dinitrosalicylic acid
(CHEBI:53648)
has functional parent
salicylic acid
(CHEBI:16914)
3,6-dimethylsalicylic acid
(CHEBI:70733)
has functional parent
salicylic acid
(CHEBI:16914)
3-allyl-2-hydroxybenzoic acid
(CHEBI:167783)
has functional parent
salicylic acid
(CHEBI:16914)
3-formylsalicylic acid
(CHEBI:34334)
has functional parent
salicylic acid
(CHEBI:16914)
3-Hydroxyphthalic acid
(CHEBI:204117)
has functional parent
salicylic acid
(CHEBI:16914)
3-methylsalicylic acid
(CHEBI:20141)
has functional parent
salicylic acid
(CHEBI:16914)
4-[amino(carboxy)methyl]-2-hydroxybenzoic acid
(CHEBI:93904)
has functional parent
salicylic acid
(CHEBI:16914)
4-acetamidosalicylic acid
(CHEBI:63816)
has functional parent
salicylic acid
(CHEBI:16914)
4-aminosalicylic acid
(CHEBI:27565)
has functional parent
salicylic acid
(CHEBI:16914)
4-formylsalicylic acid
(CHEBI:20367)
has functional parent
salicylic acid
(CHEBI:16914)
4-hydroxymethylsalicylic acid
(CHEBI:20415)
has functional parent
salicylic acid
(CHEBI:16914)
4-methylsalicylic acid
(CHEBI:20450)
has functional parent
salicylic acid
(CHEBI:16914)
4R,5R,6S-Trihydroxy-2-hydroxymethyl-2-cyclohexen-1-one 6-(2-hydroxy-6-methylbenzoate)
(CHEBI:174940)
has functional parent
salicylic acid
(CHEBI:16914)
5-(diethylsulfamoyl)-2-hydroxybenzoic acid [2-oxo-2-[4-(trifluoromethoxy)anilino]ethyl] ester
(CHEBI:123403)
has functional parent
salicylic acid
(CHEBI:16914)
5-[amino(carboxy)methyl]-2-hydroxybenzoic acid
(CHEBI:93840)
has functional parent
salicylic acid
(CHEBI:16914)
5-formylsalicylic acid
(CHEBI:137371)
has functional parent
salicylic acid
(CHEBI:16914)
5-nitrososalicylic acid
(CHEBI:143303)
has functional parent
salicylic acid
(CHEBI:16914)
6-((8Z,11Z,14Z)-heptadeca-8,11,14-trien-1-yl)salicylic acid
(CHEBI:186627)
has functional parent
salicylic acid
(CHEBI:16914)
6-((Z)-pentadec-10-en-1-yl)salicylic acid
(CHEBI:186923)
has functional parent
salicylic acid
(CHEBI:16914)
6-((Z)-pentadec-8-en-1-yl)salicylic acid
(CHEBI:193466)
has functional parent
salicylic acid
(CHEBI:16914)
6-formylsalicylic acid
(CHEBI:208549)
has functional parent
salicylic acid
(CHEBI:16914)
6-hydroxy platensimycin A1 methyl ester
(CHEBI:68270)
has functional parent
salicylic acid
(CHEBI:16914)
6-methylsalicylic acid
(CHEBI:17637)
has functional parent
salicylic acid
(CHEBI:16914)
O-(S-2-hydroxybenzoylpantetheine-4'-phosphoryl)-L-serine residue
(CHEBI:86462)
has functional parent
salicylic acid
(CHEBI:16914)
D-glucosyl salicylate
(CHEBI:133564)
has functional parent
salicylic acid
(CHEBI:16914)
acetylsalicylic acid
(CHEBI:15365)
has functional parent
salicylic acid
(CHEBI:16914)
Ampelomin G
(CHEBI:223031)
has functional parent
salicylic acid
(CHEBI:16914)
anacardic acid
(CHEBI:2696)
has functional parent
salicylic acid
(CHEBI:16914)
Antibiotic SB 202742
(CHEBI:174937)
has functional parent
salicylic acid
(CHEBI:16914)
Benzyl salicylate
(CHEBI:165211)
has functional parent
salicylic acid
(CHEBI:16914)
Butyl salicylate
(CHEBI:173949)
has functional parent
salicylic acid
(CHEBI:16914)
Chloropupukeananin
(CHEBI:216291)
has functional parent
salicylic acid
(CHEBI:16914)
Chloropupukeanone A
(CHEBI:207995)
has functional parent
salicylic acid
(CHEBI:16914)
Choline salicylate
(CHEBI:3668)
has functional parent
salicylic acid
(CHEBI:16914)
diflunisal
(CHEBI:39669)
has functional parent
salicylic acid
(CHEBI:16914)
Ethyl 4-ethoxy-2-hydroxy-3,6-dimethylbenzoate
(CHEBI:214582)
has functional parent
salicylic acid
(CHEBI:16914)
Ethylhexyl salicylate
(CHEBI:88639)
has functional parent
salicylic acid
(CHEBI:16914)
Gentisic acid sodium
(CHEBI:189437)
has functional parent
salicylic acid
(CHEBI:16914)
Gibbestatin B
(CHEBI:220560)
has functional parent
salicylic acid
(CHEBI:16914)
Ginkgoic acid
(CHEBI:5354)
has functional parent
salicylic acid
(CHEBI:16914)
Ginkgolic Acid C17-1
(CHEBI:228873)
has functional parent
salicylic acid
(CHEBI:16914)
Glycerol 1-hydroxy-2,5-dimethyl benzoate
(CHEBI:227951)
has functional parent
salicylic acid
(CHEBI:16914)
hydroxytetracaine
(CHEBI:135162)
has functional parent
salicylic acid
(CHEBI:16914)
Isoamyl salicylate
(CHEBI:173601)
has functional parent
salicylic acid
(CHEBI:16914)
Isobutyl salicylate
(CHEBI:173947)
has functional parent
salicylic acid
(CHEBI:16914)
isopropyl salicylate
(CHEBI:38703)
has functional parent
salicylic acid
(CHEBI:16914)
menthyl salicylate
(CHEBI:135976)
has functional parent
salicylic acid
(CHEBI:16914)
mesalamine
(CHEBI:6775)
has functional parent
salicylic acid
(CHEBI:16914)
Methyl 2,6-dihydroxybenzoate
(CHEBI:192874)
has functional parent
salicylic acid
(CHEBI:16914)
Methyl 2-(10-heptadecenyl)-6-hydroxybenzoate
(CHEBI:169431)
has functional parent
salicylic acid
(CHEBI:16914)
Methyl 4-(4,6-dihydroxy-5-methoxy-2,5-dimethyl-3-oxocyclohexen-1-yl)oxy-2-hydroxy-3,6-dimethylbenzoate
(CHEBI:181274)
has functional parent
salicylic acid
(CHEBI:16914)
Methyl 5-chloro-2-hydroxybenzoate
(CHEBI:194865)
has functional parent
salicylic acid
(CHEBI:16914)
methyl salicylate
(CHEBI:31832)
has functional parent
salicylic acid
(CHEBI:16914)
Nabscebetain A
(CHEBI:206787)
has functional parent
salicylic acid
(CHEBI:16914)
Nabscebetain B
(CHEBI:206794)
has functional parent
salicylic acid
(CHEBI:16914)
olsalazine
(CHEBI:7770)
has functional parent
salicylic acid
(CHEBI:16914)
Phenethyl salicylate
(CHEBI:173744)
has functional parent
salicylic acid
(CHEBI:16914)
phenyl salicylate
(CHEBI:34918)
has functional parent
salicylic acid
(CHEBI:16914)
Phomone A
(CHEBI:205846)
has functional parent
salicylic acid
(CHEBI:16914)
Pleoniol C
(CHEBI:214724)
has functional parent
salicylic acid
(CHEBI:16914)
promysalin
(CHEBI:171658)
has functional parent
salicylic acid
(CHEBI:16914)
Roccellatol
(CHEBI:220613)
has functional parent
salicylic acid
(CHEBI:16914)
Salaceyin A
(CHEBI:224587)
has functional parent
salicylic acid
(CHEBI:16914)
Salaceyin B
(CHEBI:220151)
has functional parent
salicylic acid
(CHEBI:16914)
salicylamides
(CHEBI:53443)
has functional parent
salicylic acid
(CHEBI:16914)
salicylic acid-d4
(CHEBI:178057)
has functional parent
salicylic acid
(CHEBI:16914)
salsalate
(CHEBI:9014)
has functional parent
salicylic acid
(CHEBI:16914)
valerylsalicylic acid
(CHEBI:78250)
has functional parent
salicylic acid
(CHEBI:16914)
salicylate
(CHEBI:30762)
is conjugate base of
salicylic acid
(CHEBI:16914)
2-hydroxybenzoyl group
(CHEBI:60335)
is substituent group from
salicylic acid
(CHEBI:16914)
|
2-carboxyphenol
|
NIST Chemistry WebBook
|
2-HYDROXYBENZOIC ACID
|
PDBeChem
|
o-carboxyphenol
|
NIST Chemistry WebBook
|
o-Hydroxybenzoic acid
|
KEGG COMPOUND
|
o-hydroxybenzoic acid
|
NIST Chemistry WebBook
|
Salicylic acid
|
KEGG COMPOUND
|
2416
|
DrugCentral
|
C00000206
|
KNApSAcK
|
C00805
|
KEGG COMPOUND
|
CPD-110
|
MetaCyc
|
D00097
|
KEGG DRUG
|
DB00936
|
DrugBank
|
HMDB0001895
|
HMDB
|
LSM-4763
|
LINCS
|
SAL
|
PDBeChem
|
Salicylic_Acid
|
Wikipedia
|
View more database links |
3418
|
Gmelin Registry Number
|
Gmelin
|
69-72-7
|
CAS Registry Number
|
KEGG COMPOUND
|
69-72-7
|
CAS Registry Number
|
NIST Chemistry WebBook
|
69-72-7
|
CAS Registry Number
|
ChemIDplus
|
774890
|
Reaxys Registry Number
|
Reaxys
|
Li X, Zhang Y (2020) A structural view of salicylic acid perception. Nature plants 6, 1197-1198 [PubMed:32807953] | Gibbs S, Kosten I, Veldhuizen R, Spiekstra S, Corsini E, Roggen E, Rustemeyer T, Feilzer AJ, Kleverlaan CJ (2018) Assessment of metal sensitizer potency with the reconstructed human epidermis IL-18 assay. Toxicology 393, 62-72 [PubMed:29079364] [show Abstract] According to the new EU Medical Devices (MDR) legislation coming into effect in 2017, manufactures will have to comply with higher standards of quality and safety for medical devices in order to meet common safety concerns regarding such products. Metal alloys are extensively used in dentistry and medicine (e.g. orthopedic surgery and cardiology) even though clinical experience suggests that many metals are sensitizers. The aim of this study was to further test the applicability domain of the in vitro reconstructed human epidermis (RhE) IL-18 assay developed to identify contact allergens and in doing so: i) determine whether different metal salts, representing leachables from metal alloys used in medical devices, could be correctly labelled and classified; and ii) assess the ability of different salts for the same metal to penetrate the skin stratum corneum. Twenty eight chemicals including 15 metal salts were topically exposed to RhE. Nickel, chrome, gold, palladium were each tested in two different salt forms, and titanium in 4 different salt forms. Metal salts were labelled (YES/NO) as sensitizer if a threshold of more than 5 fold IL18 release was reached. The in vitro estimation of expected sensitization induction level (potency) was assessed by interpolating in vitro EC50 and IL-18 SI2 with LLNA EC3 and human NOEL values from standard reference curves generated using DNCB (extreme) and benzocaine (weak). Metal salts, in contrast to other chemical sensitizers and with the exception of potassium dichromate (VI) and cobalt (II) chloride, were not identified as contact allergens since they only induced a small or no increase in IL-18 production. This finding was not related to a lack of stratum corneum skin penetration since EC50 values (decrease in metabolic activity; MTT assay) were obtained after topical RhE exposure to 8 of the 15 metal salts. For nickel, gold and palladium salts, differences in EC50 values between two salts for the same metal could not be attributed to differences in molarity or valency. For chrome salts the difference in EC50 values may be explained by different valencies (VI vs. III), but not by molarity. In general, metal salts were classified as weaker sensitizers than was indicated from in vivo LLNA EC3 and NOEL data. Our in vitro results show that metals are problematic chemicals to test, in line with the limited number of standardized human and animal studies, which are not currently considered adequate to predict systemic hypersensitivity or autoimmunity, and despite clinical experience, which clearly shows that many metals are indeed a risk to human health. | Roux A, Xu Y, Heilier JF, Olivier MF, Ezan E, Tabet JC, Junot C (2012) Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-Orbitrap mass spectrometer. Analytical chemistry 84, 6429-6437 [PubMed:22770225] [show Abstract] Metabolic profiles of biofluids obtained by atmospheric pressure ionization mass spectrometry-based technologies contain hundreds to thousands of features, most of them remaining unknown or at least not characterized in analytical systems. We report here on the annotation of the human adult urinary metabolome and metabolite identification from electrospray ionization mass spectrometry (ESI-MS)-based metabolomics data sets. Features of biological interest were first of all annotated using the ESI-MS database of the laboratory. They were also grouped, thanks to software tools, and annotated using public databases. Metabolite identification was achieved using two complementary approaches: (i) formal identification by matching chromatographic retention times, mass spectra, and also product ion spectra (if required) of metabolites to be characterized in biological data sets to those of reference compounds and (ii) putative identification from biological data thanks to MS/MS experiments for metabolites not available in our chemical library. By these means, 384 metabolites corresponding to 1484 annotated features (659 in negative ion mode and 825 in positive ion mode) were characterized in human urine samples. Of these metabolites, 192 and 66 were formally and putatively identified, respectively, and 54 are reported in human urine for the first time. These lists of features could be used by other laboratories to annotate their ESI-MS metabolomics data sets. | Vlot AC, Dempsey DA, Klessig DF (2009) Salicylic Acid, a multifaceted hormone to combat disease. Annual review of phytopathology 47, 177-206 [PubMed:19400653] [show Abstract] For more than 200 years, the plant hormone salicylic acid (SA) has been studied for its medicinal use in humans. However, its extensive signaling role in plants, particularly in defense against pathogens, has only become evident during the past 20 years. This review surveys how SA in plants regulates both local disease resistance mechanisms, including host cell death and defense gene expression, and systemic acquired resistance (SAR). Genetic studies reveal an increasingly complex network of proteins required for SA-mediated defense signaling, and this process is amplified by several regulatory feedback loops. The interaction between the SA signaling pathway and those regulated by other plant hormones and/or defense signals is also discussed. | Chen Z, Zheng Z, Huang J, Lai Z, Fan B (2009) Biosynthesis of salicylic acid in plants. Plant signaling & behavior 4, 493-496 [PubMed:19816125] [show Abstract] Salicylic acid (SA) is an important signal molecule in plants. Two pathways of SA biosynthesis have been proposed in plants. Biochemical studies using isotope feeding have suggested that plants synthesize SA from cinnamate produced by the activity of phenylalanine ammonia lyase (PAL). Silencing of PAL genes in tobacco or chemical inhibition of PAL activity in Arabidopsis, cucumber and potato reduces pathogen-induced SA accumulation. Genetic studies, on the other hand, indicate that the bulk of SA is produced from isochorismate. In bacteria, SA is synthesized from chorismate through two reactions catalyzed by isochorismate synthase (ICS) and isochorismate pyruvate lyase (IPL). Arabidopsis contains two ICS genes but has no gene encoding proteins similar to the bacterial IPL. Thus, how SA is synthesized in plants is not fully elucidated. Two recently identified Arabidopsis genes, PBS3 and EPS1, are important for pathogen-induced SA accumulation. PBS3 encodes a member of the acyl-adenylate/thioester-forming enzyme family and EPS1 encodes a member of the BAHD acyltransferase superfamily. PBS3 and EPS1 may be directly involved in the synthesis of an important precursor or regulatory molecule for SA biosynthesis. The pathways and regulation of SA biosynthesis in plants may be more complicated than previously thought. | Herrmann M (2003) Salicylic acid: an old dog, new tricks, and staphylococcal disease. The Journal of clinical investigation 112, 149-151 [PubMed:12865403] [show Abstract] Aspirin has been shown to cause a reduction in the virulence of Staphylococcus aureus-associated endocarditis. A new study reveals that salicylic acid, the major metabolite of aspirin, acts at the level of transcription to downregulate the production of fibrinogen, fibronectin, and alpha-hemolysin - virulence factors necessary for bacterial replication in host tissues and, now, potential therapeutic targets. | Chipperfield JR, Ratledge C (2000) Salicylic acid is not a bacterial siderophore: a theoretical study. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 13, 165-168 [PubMed:11016405] [show Abstract] Using a newly available program for calculating the concentrations and speciation of various ions (Pettit, LD & Powell KJ, 'SolEq' Academic Software, 1999), we have calculated that at pH 7 the amount of free Fe(III) present in an aqueous solution is 1.4 x 10(-9) M and not 10(-18) M as is usually quoted. In the presence of salicylic acid, included in the calculations at 10(-4) M, the solubility of Fe(III) is increased to only 9.8 x 10(-9) M suggesting that salicylate is unable to act as a siderophore although it is produced as an extracellular product by several bacterial genera when grown iron deficiently. In the presence of 40 mM phosphate, the soluble Fe(III) concentration is decreased by 10(4) at pH 7 and again this is hardly affected by the presence of salicylate. Thus, for microorganisms grown either in vitro or in vivo, salicylate is unlikely to function as a iron solubilizing agent. The same conclusions may also apply to 2,3-dihydroxybenzoic acid. | Varga JM, Kalchschmid G, Klein GF, Fritsch P (1991) Mechanism of allergic cross-reactions--I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody. Molecular immunology 28, 641-654 [PubMed:1650428] [show Abstract] A recently developed solid-phase binding assay was used to investigate the specificity of ligand binding to a mouse monoclonal anti-dinitrophenyl IgE [IgE(aDNP)]. All DNP-amino acids, that were tested, inhibited the binding of radio-labeled IgE(aDNP) to DNP covalently attached to polystyrene microtiter plates; however, the concentration for 50% inhibition varied within four orders of magnitude, DNP-L-serine being the most, DNP-proline the least potent inhibitor. In addition to DNP analogues a large number (2074) of drugs and other compounds were tested for their ability to compete with DNP for the binding site of IgE(aDNP). At the concentrations used for screening 59% of the compounds had no significant inhibition; 19% inhibited the binding of IgE(aDNP) more than 50%. Several families of compounds (tetracyclines, polymyxines, phenotiazines, salicylates and quinones) of effective competitors were found. Within these families change in the functional groups attached to the "family stem" had major effects on the affinity of ligand binding. The occurrence frequencies of interactions of ligands with IgE(aDNP) is in good agreement with a semi-empirical model for multispecific antibody-ligand interactions. | Schneider CH, Kasper MF, de Weck AL, Rolli H, Angst BD (1987) Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationships. Allergy 42, 597-603 [PubMed:3425858] [show Abstract] Based on the 1-phenyl-2,3-dimethyl-3-pyrazolin-5-one series and on the 1,2-diphenyl-pyrazolidine-3,5-dione series of drugs, haptenic reagents and conjugates were synthesized and evaluated by passive cutaneous anaphylaxis in guinea pigs, and by ELISA tests using rabbit antisera against the haptens. No cross-reactivity between pyrazolinone and pyrazolidinedione haptenic reagents was found in any of the test systems. But also within each series, the animal antibodies showed rather strict specificities upon interaction with related haptens or drugs. These results are somewhat unexpected, because the haptens were used in connection with long and flexible spacer arms. Furthermore, they are not typical for certain other drug allergies. The strict specificity reduces the diagnostic potential of the haptenic reagents when used in serological tests or in skin testing. |
|